Vertaling van "surgery in belgian hospitals " (Frans → Nederlands) :

Kurz X. , Mertens R., Ronveaux O. Antimicrobial prophylaxis in surgery in Belgian Hospitals : room for Improvement.
Kurz X. , Mertens R., Ronveaux O. Antimicrobial prophylaxis in surgery in Belgian Hospitals : room for improvement.

(BGES), Belgian Group of Digestive Oncology (BGDO), Belgian Professional Surgical Association, Belgian Section for Colorectal Surgery, a section of the Royal Belgian Society for Surgery (RBSS) Belgian Society of Gastrointestinal Endoscopy (BSGIE), Belgian Society for Pathology (BSP) and Digestive Pathology Club, Belgian Society for Radiotherapy-Oncology (BVRO/ABRO), Belgian Society of Medical Oncology (BSMO), Belgian Society of Surgical Oncology (BSSO), Royal Belgian Society of Radiology, le Collège d’oncologie, l’INAMI, la Société Royale Belge de Gastro-Entérologie, la Fondation registre du cancer et la Vlaamse Vereniging voor Gastro-Enterologie.
Belgian Group of Digestive Oncology (BGDO), Belgian Professional Surgical Association, Belgian Section for Colorectal Surgery, a section of the Royal Belgian Society for Surgery (RBSS) Belgian Society of Gastrointestinal Endoscopy (BSGIE), Belgian Society for Pathology (BSP) and Digestive Pathology Club, Belgian Society for Radiotherapy-Oncology (BVRO/ABRO), Belgian Society of Medical Oncology (BSMO), Belgian Society of Surgical Oncology (BSSO), Royal Belgian Society of Radiology, College voor Oncologie, het RIZIV, Société Royale Belge de Gastro-Entérologie, Stichting Kankerregister en de Vlaamse Vereniging voor Gastro-Enterologie.

transparency in ambulatory supplements as well as in private hospital illustrated that in Belgian hospitals nurses have, on average, to take care insurances (the percentage of people with private hospital insurance, and for more patients compared to other EU countries.
mechanisms, individual private insurances reimburse several healthcare Macro-level data on the needs should be complemented with dataa that services.

Specific residential facilities in which care can be provided in a home that there is general lack of nurses in the Belgian hospitals. Moreover, the or home-replacing environment.
Specific residential facilities in which care can be provided in a home continuously rising and changing demand for health services, due to or home-replacing environment.

The impact of the Clinical Pharmacy in the Belgian hospitals (.PDF)
The impact of the Clinical Pharmacy in the Belgian hospitals (.PDF)

Remerciements : Pour son aide précieuse relative à la méta-analyse : Cécile Dubois (KCE) Pour leur contribution au scoring des indicateurs : Raf Brouns et Matthieu Rutgers (Belgian Stroke Council) Pour la validation de la description de leur pays : Suède : Kiell Asplund (Chair, Risks Stroke Umea), Bo Norrving (Professor, Lund University-Steering committee member Riks stroke) Pays-Bas : Martien Limburg (Neuroloog, Flevoziekenhuis, Almere, Stichting Kennisnetwerk) Ecosse : Martin Dennis (Division of Clinical Neurosciences – Western General Hospital University of Edinburgh), Peter Langhorne (Professor of Stroke Care, Cardiovascular and Medical Sciences Division – University of Glasgow) Grande-Bretagne : Patrick Gompertz (Barts and the London Brain Attack Center, London), Gill Gluckie (Clinical lead, stroke, Guy’s and St. Thomas’ hospital, clinical lead, S/East London stroke network) France : France Woimant (Service de neurologie, hôpital Lariboisière, Paris – “Agence Régionale de Santé – Ilede-France”), Didier Leys (Département de neurologie, Hôpital universitaire de Lille) Allemagne : Peter Heuschmann (Neurologische klinik und poliklinik, Universitätsklinikum Würzburg) German Stroke Register Study Group), E. Bernd Ringelstein (Neurologische klinik und poliklinik, Universitätsklinikum Münster)
Acknowledgements: Voor haar waardevolle bijdrage in het gedeelte over meta-analyse: Cécile Dubois (KCE) Voor hun bijdrage bij het scoren van de indicatoren: Raf Brouns en Matthieu Rutgers (Belgian Stroke Council) Voor het valideren van de informatie over hun land: Zweden: Kiell Asplund (Chair, Risks Stroke Umeal), Bo Norrving (Professor, Lund University-Steering committee member Riks stroke) Nederland: Martien Limburg (Neuroloog, Flevoziekenhuis, Almere, Stichting Kennisnetwerk); Schotland: Martin Dennis (Division of Clinical Neurosciences – Western General Hospital University of Edinburgh), Peter Langhorne (Professor of Stroke Care, Cardiovascular and Medical Sciences Division – University of Glasgow) Verenigd Koninkrijk: Patrick Gompertz (Barts and the London Brain Attack Center, London), Gill Gluckie (Clinical lead, stroke, Guy’s and St. Thomas’ hospital, clinical lead, S/East London stroke network) Frankrijk: France Woimant (Service de neurologie, hôpital Lariboisière, Paris – “Agence Régionale de Santé – Ile-de-France”), Didier Leys (Département de neurologie, Hôpital universitaire de Lille) Duitsland: Peter Heuschmann (Neurologische klinik und poliklinik, Universitätsklinikum Würzburg) German Stroke Register Study Group), E. Bernd Ringelstein (Neurologische klinik und poliklinik, Universitätsklinikum Münster)

1 Le comité directeur de Procare est composé des membres suivants: Belgian Group for Endoscopic Surgery
1 De stuurgroep van Procare bestaat uit volgende leden: Belgian Group for Endoscopic Surgery (BGES),

Pour l’assistance technique et scientifique, particulièrement au profit du Conseil technique des implants , et l’évaluation : la Belgian Association for Cardio-Thoracic Surgery (BACTS).
Voor de technisch-wetenschappelijke bijstand, in de eerste plaats ten behoeve van de Technische Raad voor implantaten, en de evaluatie: de Belgian Association for Cardio-Thoracic Surgery (BACTS).

In this science - policy advisory report, the Belgian Superior Health Council provides recommendations regarding infection control (Aspergillus and other mould, Legionella, etc) throughout a hospital design and construction project, as well as renovation works and other
In this science - policy advisory report, the Belgian Superior Health Council provides recommendations regarding infection control (Aspergillus and other mould, Legionella, etc) throughout a hospital design and construction project, as well as renovation works and other technical interventions carried out in health facilities; these recommendations are intended for the internal and external players involved in these activities.

White blood cells : ASA I en II : No Sedimentation : ASA I : No Haemostasis : ASA I en II : No (except in case of bloody surgery) Renal function : Na and K : ASA I en II : No Creatinine : ASA I en II : No, except > 60 y Random glucose : ASA I : No Urine analysis : ASA I: No Pregnancy test : ask questions ALAT : ASA I en II : No Hepatitis B : protection of hospital staff
White blood cells : ASA I en II : No Sedimentation : ASA I : No Haemostasis : ASA I en II : No (except in case of bloody surgery) Renal function : Na and K : ASA I en II : No Creatinine : ASA I en II : No, except > 60 y Random glucose : ASA I : No Urine analysis : ASA I: No